Colonic mucosal diffuse congestion associated with Osimertinib
Journal of Oncology Pharmacy Practice · 2023
DOI: 10.1177/10781552231184182 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Oncology Pharmacy Practice, 2023. Verfasst von Xiao-Jun Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology & Hepatology, Dazhou Integrated TCM and Western Medicine Hospital: Dazhou Second People's Hospital, Dazhou, Sichuan, C…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Introduction
Non-small cell lung cancer (NSCLC) is the most common histological subtype of lung cancer. Osimertinib has been recommended as first-line treatment of advanced NSCLC with EGFR mutations. Previous studies have only reported cases of gastrointestinal bleeding due to Erlotinib and gefitinib, but to date, always no cases of gastrointestinal bleeding due to Osimertinib have been reported. Case Report We report a case of a female patient with NSCLC with EFGR mutation. After 1.5 years of treatment with Osimertinib, a colonoscopy showed diffuse congestion of the colonic mucosa. Management and Outcome The patient’s symptoms of blood in the stool disappeared, after stopping Osimertinib and giving mucosal protection treatment for 1 week.
Discussion
Osimertinib may have contributed to gastrointestinal bleeding because no recurrent bleeding was observed after discontinuation of treatment. Physicians and patients should be aware that osimertinib may increase the risk of gastrointestinal bleeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology & Hepatology, Dazhou Integrated TCM and Western Medicine Hospital: Dazhou Second People's Hospital, Dazhou, Sichuan, China.
- Department of Gastroenterology & Hepatology, Bishan District Traditional Chinese Medicine Hospital, Bishan, Chongqing, China.
- Ningxia Medical University, Yinchuan, Ningxia, China.
ORCID-Profile: Xiao-Jun Ren
Zitieren
APA
Ren, X. J., Lei, M. H., Cheng, Y. X., & Luo, Y. (2023). Colonic mucosal diffuse congestion associated with Osimertinib. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552231184182
Vancouver
Ren XJ, Lei MH, Cheng YX, Luo Y. Colonic mucosal diffuse congestion associated with Osimertinib. Journal of Oncology Pharmacy Practice. 2023. doi:10.1177/10781552231184182
BibTeX
@article{Ren2023,
author = {Ren, Xiao-Jun and Lei, Ming-Hong and Cheng, Ying-Xia and Luo, Yun},
title = {Colonic mucosal diffuse congestion associated with Osimertinib},
journal = {Journal of Oncology Pharmacy Practice},
year = {2023},
doi = {10.1177/10781552231184182}
}
EUVIMED